Health Technology Assessment and Economic Evaluation

This theme presents CHIEF’s contribution to health technology assessment (HTA), economic evaluation, cost-effectiveness analysis, cost-utility analysis, budget impact analysis, multicriteria decision analysis, and value-for-money assessment. These publications support priority-setting and evidence-informed decisions for health technologies, medicines, diagnostics, and clinical interventions in Indonesia and beyond.

What is the Value of Developing an HTA Process?

Budi Hidayat; Subhash Pokhrel.
International Journal of Environmental Research and Public Health, 2010.
Topic tags: count data model, health insurance demand, econometrics, healthcare demand.

A decade of HTA in Indonesia: Methodological challenges in conducting economic evaluation

Septiara Putri; co-author.
Health Policy and Technology, 2024.
Topic tags: HTA Indonesia, economic evaluation, methodology, health policy.

A framework for improved collaboration on HTA in the Asia-Pacific region: A role for HTAsiaLink

Ryan Rachmad Nugraha; Christian Suharlim; and co-authors including Budi Hidayat.
International Journal of Technology Assessment in Health Care, 2024.
Topic tags: HTA, Asia-Pacific, HTAsiaLink, regional collaboration.

Does Trastuzumab Offer Good Value for Money for Breast Cancer Patients with Metastasis in Indonesia?

Erna Kristin; Dwi Endarti; Levina Chandra Khoe; and co-authors including Budi Hidayat and Mardiati Nadjib.
Asian Pacific Journal of Cancer Prevention, 2022.
Topic tags: trastuzumab, breast cancer, value for money, economic evaluation.

Cetuximab as first-line treatment for metastatic colorectal cancer (mCRC): a model-based economic evaluation in Indonesia setting

Septiara Putri; and co-authors.
BMC Cancer, 2023.
Topic tags: cetuximab, colorectal cancer, model-based economic evaluation, HTA.

Adding rituximab to chemotherapy for diffuse large B-cell lymphoma patients in Indonesia: a cost utility and budget impact analysis

Septiara Putri; and co-authors.
BMC Health Services Research, 2022.
Topic tags: rituximab, lymphoma, cost-utility analysis, budget impact analysis.

Supporting dialysis policy for end stage renal disease (ESRD) in Indonesia: an updated cost-effectiveness model

Septiara Putri; and co-authors.
BMC Research Notes, 2022.
Topic tags: dialysis, ESRD, cost-effectiveness, health policy.

Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia

Septiara Putri; and co-authors.
BMC Health Services Research, 2019.
Topic tags: sildenafil, pulmonary arterial hypertension, economic evaluation, HTA.

Cost and affordability of scaling up tuberculosis diagnosis using Xpert MTB/RIF testing in West Java, Indonesia

Septiara Putri; and co-authors.
PLOS ONE, 2022.
Topic tags: tuberculosis, Xpert MTB/RIF, affordability, diagnostic scale-up.

Guidance toward the implementation of multicriteria decision analysis framework in developing countries

András Inotai; Huong Thanh Nguyen; Budi Hidayat; and co-authors.
Expert Review of Pharmacoeconomics and Outcomes Research, 2018.
Topic tags: MCDA, developing countries, decision analysis, HTA.